• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ZYNE

ZYNE

Zynerba Pharmaceuticals, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD1.30

+0.03 (+2.36%)

Company Profile

CEO

Armando Anido MBA

IPO Date

2015-08-05

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.26

Prev. Close

$1.27

Day Low

$1.26

Day High

$1.34

52W Low

$0.25

52W High

$1.40

Market Cap

$0.07B

Volume

0.86M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

7.1%

Avg Negative

2.0%

Avg Neutral

91.1%

News Feed

Why Weed Penny Stocks Are Up Today & 3 to Watch as Tilray Skyrockets

PennyStocks·7/28/2021·↑ positive

Zynerba Pharmaceuticals to Present at the Ladenburg Thalmann Virtual Healthcare Conference

GlobeNewsWire·7/7/2021·↑ positive

Zynerba's Zygel Improves Sleep In Children With Severe Epilepsies

Benzinga·6/11/2021·↑ positive

Zynerba Pharmaceuticals showcases Zygel study poster at annual SLEEP meeting

Proactive Investors·6/11/2021·↑ positive

Zynerba Pharmaceuticals Presents Sleep Data from Study of Zygel™ in Children and Adolescents with Both Developmental and Epileptic Encephalopathies (DEE) and Autism Spectrum Disorder (ASD) at the Associated Professional Sleep Societies SLEEP 2021 Annual Meeting

GlobeNewsWire·6/11/2021·↑ positive

Smoked! How the Hottest Cannabis Stocks Fared This Week

Schaeffers Research·6/11/2021·↑ positive

Zynerba Pharmaceuticals Announces Adjournment of Annual Meeting

GlobeNewsWire·6/9/2021·↓ negative

Zynerba Pharmaceuticals Announces Acceptance of Poster at the Associated Professional Sleep Societies SLEEP 2021 Annual Meeting

GlobeNewsWire·6/4/2021·↑ positive

Zynerba Pharmaceuticals Announces Presentation of Efficacy and Safety Findings in Children and Adolescents with Autism Spectrum Disorder (ASD) and Related Disorders at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

GlobeNewsWire·6/3/2021·↑ positive

Zynerba Pharmaceuticals Announces Acceptance of Poster at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

GlobeNewsWire·5/27/2021·↑ positive